These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28340172)

  • 1. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor.
    Lee YE; Choi SA; Kwack PA; Kim HJ; Kim IH; Wang KC; Phi JH; Lee JY; Chong S; Park SH; Park KD; Hwang DW; Joo KM; Kim SK
    Neuro Oncol; 2017 Aug; 19(8):1079-1087. PubMed ID: 28340172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
    Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
    Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT).
    Jangra A; Choi SA; Yang J; Koh EJ; Phi JH; Lee JY; Wang KC; Kim SK
    Cancer Lett; 2020 Aug; 486():38-45. PubMed ID: 32428661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro.
    Koh HK; Seo SY; Kim JH; Kim HJ; Chie EK; Kim SK; Kim IH
    Cancer Res Treat; 2019 Apr; 51(2):696-705. PubMed ID: 30121967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
    Wang K; Michelakos T; Wang B; Shang Z; DeLeo AB; Duan Z; Hornicek FJ; Schwab JH; Wang X
    Cancer Lett; 2021 May; 505():37-48. PubMed ID: 33582212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
    Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
    Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
    Serra R; Zhao T; Huq S; Gorelick NL; Casaos J; Cecia A; Mangraviti A; Eberhart C; Bai R; Olivi A; Brem H; Jackson EM; Tyler B
    PLoS One; 2021; 16(11):e0251957. PubMed ID: 34731160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.
    Rubens JA; Wang SZ; Price A; Weingart MF; Allen SJ; Orr BA; Eberhart CG; Raabe EH
    Neuro Oncol; 2017 Oct; 19(10):1361-1371. PubMed ID: 28582547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.
    Zirjacks L; Stransky N; Klumpp L; Prause L; Eckert F; Zips D; Schleicher S; Handgretinger R; Huber SM; Ganser K
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor.
    Kao CL; Huang PI; Tsai PH; Tsai ML; Lo JF; Lee YY; Chen YJ; Chen YW; Chiou SH
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):219-28. PubMed ID: 19362240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
    Shahab S; Rubens J; Kaur H; Sweeney H; Eberhart CG; Raabe EH
    J Neuropathol Exp Neurol; 2020 Jul; 79(7):746-753. PubMed ID: 32472116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.
    Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z
    Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
    Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C
    Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram.
    Cong J; Wang Y; Zhang X; Zhang N; Liu L; Soukup K; Michelakos T; Hong T; DeLeo A; Cai L; Sabbatino F; Ferrone S; Lee H; Levina V; Fuchs B; Tanabe K; Lillemoe K; Ferrone C; Wang X
    Cancer Lett; 2017 Nov; 409():9-19. PubMed ID: 28864067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.
    Weingart MF; Roth JJ; Hutt-Cabezas M; Busse TM; Kaur H; Price A; Maynard R; Rubens J; Taylor I; Mao XG; Xu J; Kuwahara Y; Allen SJ; Erdreich-Epstein A; Weissman BE; Orr BA; Eberhart CG; Biegel JA; Raabe EH
    Oncotarget; 2015 Feb; 6(5):3165-77. PubMed ID: 25638158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion channels in pediatric CNS Atypical Teratoid/Rhabdoid Tumor (AT/RT) cells: potential targets for novel therapeutic agents.
    Banderali U; Jayanthan A; Hoeksema KA; Narendran A; Giles WR
    J Neurooncol; 2012 Mar; 107(1):111-9. PubMed ID: 21971736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
    Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
    Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
    Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.